| Behavioral Health Services | |
|
441 N Main St Alturas CA 96101-3457 | |
| (530) 233-6312 | |
| (530) 233-6339 |
| Full Name | Behavioral Health Services |
|---|---|
| Speciality | Behavior Analyst |
| Location | 441 N Main St, Alturas, California |
| Authorized Official Name and Position | Karen E. Stockton (DIRECTOR, HEALTH SERVICES) |
| Authorized Official Contact | 5302336312 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Behavioral Health Services 441 N Main St Alturas CA 96101-3457 Ph: (530) 233-6312 | Behavioral Health Services 441 N Main St Alturas CA 96101-3457 Ph: (530) 233-6312 |
| NPI Number | 1396858668 |
|---|---|
| Provider Enumeration Date | 08/17/2006 |
| Last Update Date | 08/14/2012 |
| Medicare PECOS PAC ID | 5193987808 |
|---|---|
| Medicare Enrollment ID | O20120425000476 |
News Archive
Women with acute heart failure have similar in-hospital mortality to men but are less treated in the real world, according to results from the global ALARM-HF registry presented today at the ESC Congress 2012. The findings were presented by Dr John T. Parissis from Greece.
Pharmasset, Inc., a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended March 31, 2010.
Vignet Inc., today announced its Connected Health Services platform infrastructure for mobile health (mHealth) devices and services. The new "person-centered" platform allows users to capture, aggregate, analyze and share data with their mobile devices, leveraging any wired or wireless interface, such as Bluetooth, ZigBee, Bluetooth LE and USB.
In Austria every year approx. 1,500 postmenopausal patients, that is, after the climacteric period, are affected by stage II breast cancer. This means that in these women tumour cells have already been found in the lymph nodes and that the risk of metastases appearing in the future course of the illness is significantly increased.
NexMed, Inc., a developer of products based on the NexACT® technology, today announced that it has completed its post hoc analysis of NM100060, the Company's topically-applied treatment for onychomycosis, commonly known as nail fungus. Based on this analysis, NexMed seeks to pursue signing a partner for further development of the product.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396858668 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103K00000X | Behavior Analyst | (* (Not Available)) | Primary |
| Provider Name | Martin A Dawson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1073653861 PECOS PAC ID: 8527080498 Enrollment ID: I20051220000990 |
News Archive
Women with acute heart failure have similar in-hospital mortality to men but are less treated in the real world, according to results from the global ALARM-HF registry presented today at the ESC Congress 2012. The findings were presented by Dr John T. Parissis from Greece.
Pharmasset, Inc., a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended March 31, 2010.
Vignet Inc., today announced its Connected Health Services platform infrastructure for mobile health (mHealth) devices and services. The new "person-centered" platform allows users to capture, aggregate, analyze and share data with their mobile devices, leveraging any wired or wireless interface, such as Bluetooth, ZigBee, Bluetooth LE and USB.
In Austria every year approx. 1,500 postmenopausal patients, that is, after the climacteric period, are affected by stage II breast cancer. This means that in these women tumour cells have already been found in the lymph nodes and that the risk of metastases appearing in the future course of the illness is significantly increased.
NexMed, Inc., a developer of products based on the NexACT® technology, today announced that it has completed its post hoc analysis of NM100060, the Company's topically-applied treatment for onychomycosis, commonly known as nail fungus. Based on this analysis, NexMed seeks to pursue signing a partner for further development of the product.
› Verified 3 days ago
| Provider Name | Mindy L Crookham |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1467645382 PECOS PAC ID: 3779673363 Enrollment ID: I20071219000695 |
News Archive
Women with acute heart failure have similar in-hospital mortality to men but are less treated in the real world, according to results from the global ALARM-HF registry presented today at the ESC Congress 2012. The findings were presented by Dr John T. Parissis from Greece.
Pharmasset, Inc., a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended March 31, 2010.
Vignet Inc., today announced its Connected Health Services platform infrastructure for mobile health (mHealth) devices and services. The new "person-centered" platform allows users to capture, aggregate, analyze and share data with their mobile devices, leveraging any wired or wireless interface, such as Bluetooth, ZigBee, Bluetooth LE and USB.
In Austria every year approx. 1,500 postmenopausal patients, that is, after the climacteric period, are affected by stage II breast cancer. This means that in these women tumour cells have already been found in the lymph nodes and that the risk of metastases appearing in the future course of the illness is significantly increased.
NexMed, Inc., a developer of products based on the NexACT® technology, today announced that it has completed its post hoc analysis of NM100060, the Company's topically-applied treatment for onychomycosis, commonly known as nail fungus. Based on this analysis, NexMed seeks to pursue signing a partner for further development of the product.
› Verified 3 days ago
| Provider Name | Edward P Richert |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1376586529 PECOS PAC ID: 6901989052 Enrollment ID: I20091009000185 |
News Archive
Women with acute heart failure have similar in-hospital mortality to men but are less treated in the real world, according to results from the global ALARM-HF registry presented today at the ESC Congress 2012. The findings were presented by Dr John T. Parissis from Greece.
Pharmasset, Inc., a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended March 31, 2010.
Vignet Inc., today announced its Connected Health Services platform infrastructure for mobile health (mHealth) devices and services. The new "person-centered" platform allows users to capture, aggregate, analyze and share data with their mobile devices, leveraging any wired or wireless interface, such as Bluetooth, ZigBee, Bluetooth LE and USB.
In Austria every year approx. 1,500 postmenopausal patients, that is, after the climacteric period, are affected by stage II breast cancer. This means that in these women tumour cells have already been found in the lymph nodes and that the risk of metastases appearing in the future course of the illness is significantly increased.
NexMed, Inc., a developer of products based on the NexACT® technology, today announced that it has completed its post hoc analysis of NM100060, the Company's topically-applied treatment for onychomycosis, commonly known as nail fungus. Based on this analysis, NexMed seeks to pursue signing a partner for further development of the product.
› Verified 3 days ago
| Provider Name | Thomas J Andrews |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1245393651 PECOS PAC ID: 7618015983 Enrollment ID: I20091130000432 |
News Archive
Women with acute heart failure have similar in-hospital mortality to men but are less treated in the real world, according to results from the global ALARM-HF registry presented today at the ESC Congress 2012. The findings were presented by Dr John T. Parissis from Greece.
Pharmasset, Inc., a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended March 31, 2010.
Vignet Inc., today announced its Connected Health Services platform infrastructure for mobile health (mHealth) devices and services. The new "person-centered" platform allows users to capture, aggregate, analyze and share data with their mobile devices, leveraging any wired or wireless interface, such as Bluetooth, ZigBee, Bluetooth LE and USB.
In Austria every year approx. 1,500 postmenopausal patients, that is, after the climacteric period, are affected by stage II breast cancer. This means that in these women tumour cells have already been found in the lymph nodes and that the risk of metastases appearing in the future course of the illness is significantly increased.
NexMed, Inc., a developer of products based on the NexACT® technology, today announced that it has completed its post hoc analysis of NM100060, the Company's topically-applied treatment for onychomycosis, commonly known as nail fungus. Based on this analysis, NexMed seeks to pursue signing a partner for further development of the product.
› Verified 3 days ago
| Provider Name | Kathleen Timbers-coggin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1407974827 PECOS PAC ID: 7618949595 Enrollment ID: I20150530000233 |
News Archive
Women with acute heart failure have similar in-hospital mortality to men but are less treated in the real world, according to results from the global ALARM-HF registry presented today at the ESC Congress 2012. The findings were presented by Dr John T. Parissis from Greece.
Pharmasset, Inc., a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended March 31, 2010.
Vignet Inc., today announced its Connected Health Services platform infrastructure for mobile health (mHealth) devices and services. The new "person-centered" platform allows users to capture, aggregate, analyze and share data with their mobile devices, leveraging any wired or wireless interface, such as Bluetooth, ZigBee, Bluetooth LE and USB.
In Austria every year approx. 1,500 postmenopausal patients, that is, after the climacteric period, are affected by stage II breast cancer. This means that in these women tumour cells have already been found in the lymph nodes and that the risk of metastases appearing in the future course of the illness is significantly increased.
NexMed, Inc., a developer of products based on the NexACT® technology, today announced that it has completed its post hoc analysis of NM100060, the Company's topically-applied treatment for onychomycosis, commonly known as nail fungus. Based on this analysis, NexMed seeks to pursue signing a partner for further development of the product.
› Verified 3 days ago
| Provider Name | Dolores C Navarro Turner |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1861774325 PECOS PAC ID: 3476849787 Enrollment ID: I20160913002621 |
News Archive
Women with acute heart failure have similar in-hospital mortality to men but are less treated in the real world, according to results from the global ALARM-HF registry presented today at the ESC Congress 2012. The findings were presented by Dr John T. Parissis from Greece.
Pharmasset, Inc., a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended March 31, 2010.
Vignet Inc., today announced its Connected Health Services platform infrastructure for mobile health (mHealth) devices and services. The new "person-centered" platform allows users to capture, aggregate, analyze and share data with their mobile devices, leveraging any wired or wireless interface, such as Bluetooth, ZigBee, Bluetooth LE and USB.
In Austria every year approx. 1,500 postmenopausal patients, that is, after the climacteric period, are affected by stage II breast cancer. This means that in these women tumour cells have already been found in the lymph nodes and that the risk of metastases appearing in the future course of the illness is significantly increased.
NexMed, Inc., a developer of products based on the NexACT® technology, today announced that it has completed its post hoc analysis of NM100060, the Company's topically-applied treatment for onychomycosis, commonly known as nail fungus. Based on this analysis, NexMed seeks to pursue signing a partner for further development of the product.
› Verified 3 days ago
| Provider Name | Elisa L Robertson |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1457456030 PECOS PAC ID: 2466749171 Enrollment ID: I20160923001185 |
News Archive
Women with acute heart failure have similar in-hospital mortality to men but are less treated in the real world, according to results from the global ALARM-HF registry presented today at the ESC Congress 2012. The findings were presented by Dr John T. Parissis from Greece.
Pharmasset, Inc., a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended March 31, 2010.
Vignet Inc., today announced its Connected Health Services platform infrastructure for mobile health (mHealth) devices and services. The new "person-centered" platform allows users to capture, aggregate, analyze and share data with their mobile devices, leveraging any wired or wireless interface, such as Bluetooth, ZigBee, Bluetooth LE and USB.
In Austria every year approx. 1,500 postmenopausal patients, that is, after the climacteric period, are affected by stage II breast cancer. This means that in these women tumour cells have already been found in the lymph nodes and that the risk of metastases appearing in the future course of the illness is significantly increased.
NexMed, Inc., a developer of products based on the NexACT® technology, today announced that it has completed its post hoc analysis of NM100060, the Company's topically-applied treatment for onychomycosis, commonly known as nail fungus. Based on this analysis, NexMed seeks to pursue signing a partner for further development of the product.
› Verified 3 days ago
| Provider Name | Alisha A Romesha |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1831530682 PECOS PAC ID: 9032488945 Enrollment ID: I20170710001292 |
News Archive
Women with acute heart failure have similar in-hospital mortality to men but are less treated in the real world, according to results from the global ALARM-HF registry presented today at the ESC Congress 2012. The findings were presented by Dr John T. Parissis from Greece.
Pharmasset, Inc., a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended March 31, 2010.
Vignet Inc., today announced its Connected Health Services platform infrastructure for mobile health (mHealth) devices and services. The new "person-centered" platform allows users to capture, aggregate, analyze and share data with their mobile devices, leveraging any wired or wireless interface, such as Bluetooth, ZigBee, Bluetooth LE and USB.
In Austria every year approx. 1,500 postmenopausal patients, that is, after the climacteric period, are affected by stage II breast cancer. This means that in these women tumour cells have already been found in the lymph nodes and that the risk of metastases appearing in the future course of the illness is significantly increased.
NexMed, Inc., a developer of products based on the NexACT® technology, today announced that it has completed its post hoc analysis of NM100060, the Company's topically-applied treatment for onychomycosis, commonly known as nail fungus. Based on this analysis, NexMed seeks to pursue signing a partner for further development of the product.
› Verified 3 days ago
| Provider Name | Stacy E Sphar |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1659777621 PECOS PAC ID: 1052786225 Enrollment ID: I20230331002533 |
News Archive
Women with acute heart failure have similar in-hospital mortality to men but are less treated in the real world, according to results from the global ALARM-HF registry presented today at the ESC Congress 2012. The findings were presented by Dr John T. Parissis from Greece.
Pharmasset, Inc., a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended March 31, 2010.
Vignet Inc., today announced its Connected Health Services platform infrastructure for mobile health (mHealth) devices and services. The new "person-centered" platform allows users to capture, aggregate, analyze and share data with their mobile devices, leveraging any wired or wireless interface, such as Bluetooth, ZigBee, Bluetooth LE and USB.
In Austria every year approx. 1,500 postmenopausal patients, that is, after the climacteric period, are affected by stage II breast cancer. This means that in these women tumour cells have already been found in the lymph nodes and that the risk of metastases appearing in the future course of the illness is significantly increased.
NexMed, Inc., a developer of products based on the NexACT® technology, today announced that it has completed its post hoc analysis of NM100060, the Company's topically-applied treatment for onychomycosis, commonly known as nail fungus. Based on this analysis, NexMed seeks to pursue signing a partner for further development of the product.
› Verified 3 days ago
| Provider Name | Julie A Williams |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1366879413 PECOS PAC ID: 6305207002 Enrollment ID: I20230727002545 |
News Archive
Women with acute heart failure have similar in-hospital mortality to men but are less treated in the real world, according to results from the global ALARM-HF registry presented today at the ESC Congress 2012. The findings were presented by Dr John T. Parissis from Greece.
Pharmasset, Inc., a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended March 31, 2010.
Vignet Inc., today announced its Connected Health Services platform infrastructure for mobile health (mHealth) devices and services. The new "person-centered" platform allows users to capture, aggregate, analyze and share data with their mobile devices, leveraging any wired or wireless interface, such as Bluetooth, ZigBee, Bluetooth LE and USB.
In Austria every year approx. 1,500 postmenopausal patients, that is, after the climacteric period, are affected by stage II breast cancer. This means that in these women tumour cells have already been found in the lymph nodes and that the risk of metastases appearing in the future course of the illness is significantly increased.
NexMed, Inc., a developer of products based on the NexACT® technology, today announced that it has completed its post hoc analysis of NM100060, the Company's topically-applied treatment for onychomycosis, commonly known as nail fungus. Based on this analysis, NexMed seeks to pursue signing a partner for further development of the product.
› Verified 3 days ago
| Provider Name | Alyssa Tierney |
|---|---|
| Provider Type | Practitioner - Marriage And Family Therapist |
| Provider Identifiers | NPI Number: 1770949349 PECOS PAC ID: 9830541812 Enrollment ID: I20240115001801 |
News Archive
Women with acute heart failure have similar in-hospital mortality to men but are less treated in the real world, according to results from the global ALARM-HF registry presented today at the ESC Congress 2012. The findings were presented by Dr John T. Parissis from Greece.
Pharmasset, Inc., a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended March 31, 2010.
Vignet Inc., today announced its Connected Health Services platform infrastructure for mobile health (mHealth) devices and services. The new "person-centered" platform allows users to capture, aggregate, analyze and share data with their mobile devices, leveraging any wired or wireless interface, such as Bluetooth, ZigBee, Bluetooth LE and USB.
In Austria every year approx. 1,500 postmenopausal patients, that is, after the climacteric period, are affected by stage II breast cancer. This means that in these women tumour cells have already been found in the lymph nodes and that the risk of metastases appearing in the future course of the illness is significantly increased.
NexMed, Inc., a developer of products based on the NexACT® technology, today announced that it has completed its post hoc analysis of NM100060, the Company's topically-applied treatment for onychomycosis, commonly known as nail fungus. Based on this analysis, NexMed seeks to pursue signing a partner for further development of the product.
› Verified 3 days ago
News Archive
Women with acute heart failure have similar in-hospital mortality to men but are less treated in the real world, according to results from the global ALARM-HF registry presented today at the ESC Congress 2012. The findings were presented by Dr John T. Parissis from Greece.
Pharmasset, Inc., a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended March 31, 2010.
Vignet Inc., today announced its Connected Health Services platform infrastructure for mobile health (mHealth) devices and services. The new "person-centered" platform allows users to capture, aggregate, analyze and share data with their mobile devices, leveraging any wired or wireless interface, such as Bluetooth, ZigBee, Bluetooth LE and USB.
In Austria every year approx. 1,500 postmenopausal patients, that is, after the climacteric period, are affected by stage II breast cancer. This means that in these women tumour cells have already been found in the lymph nodes and that the risk of metastases appearing in the future course of the illness is significantly increased.
NexMed, Inc., a developer of products based on the NexACT® technology, today announced that it has completed its post hoc analysis of NM100060, the Company's topically-applied treatment for onychomycosis, commonly known as nail fungus. Based on this analysis, NexMed seeks to pursue signing a partner for further development of the product.
› Verified 3 days ago
Youth And Family Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 112 E 2nd St, Alturas, CA 96101 Phone: 530-233-4929 | |
Modoc County Behavioral Health Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 441 N Main St, Alturas, CA 96101 Phone: 530-233-6312 Fax: 530-233-6339 |